Login to Your Account



Financings Roundup


Tuesday, June 5, 2012

• Coronado Biosciences Inc., of Burlington, Mass., filed a registration statement with the SEC for a public offering of 2 million shares of common stock. Oppenheimer & Co. Inc. and Roth Capital Partners are acting as joint book-running managers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription